Skip to main content

BCCMM board rescinds limit on NP prescribing of anabolic steroids

Jan 25, 2024

​The BCCNM board on Jan. 25, 2024, amended the NP Scope of Practice: Standards, Limits, and Conditions by rescinding the limit on prescribing anabolic steroids and their derivatives. This change takes effect immediately.


On Dec. 1, 2023, BCCNM was notified of an exemption under the Controlled Drugs and Substances Act (CDSA) titled Subsection 56(1) Class Exemption for Nurse Practitioners to Prescribe Anabolic Steroids for Therapeutic Use.

The board on Dec. 20, 2023, approved the immediate rescinding of the limit related to related to amphetamines and other designated drugs. The limit on prescribing anabolic steroids has now also been rescinded, meaning NPs can prescribe steroids beyond testosterone.


Use the Standards Support intake form to connect with the Standards & Guidance team. 

900 – 200 Granville St
Vancouver, BC  V6C 1S4

​Toll-free 1.866.880.7101 (within Canada only) ​

We acknowledge the rights and title of the First Nations on whose collective unceded territories encompass the land base colonially known as British Columbia. We give specific thanks to the hən̓q̓əmin̓əm̓ speaking peoples the xʷməθkʷəy̓əm (Musqueam) and sel̓íl̓witulh (Tsleil-Waututh) Nations and the Sḵwx̱wú7mesh-ulh Sníchim speaking Peoples the Sḵwx̱wú7mesh Úxwumixw (Squamish Nation), on whose unceded territories BCCNM’s office is located. We also give thanks for the medicines of these territories and recognize that laws, governance, and health systems tied to these lands and waters have existed here for over 9000 years.

We also acknowledge the unique and distinct rights, including rights to health and wellness, of First Nations, Métis, and Inuit peoples from elsewhere in Canada who now live in British Columbia. As leaders in the settler health system, we acknowledge our responsibilities to these rights under international, national, and provincial law.​